Biotech behemoth Monsanto was recently in the news for its merger with German pharmaceutical giant Bayer - a $66 billion deal which is reportedly the biggest yet this year and, if it goes through, may mean the end of the controversial Monsanto brand name. But if that massive merger is newsworthy, and it most certainly … Continue reading Un-Monsanto to harness CRISPR to make un-GMOs
MirrorWilderness.com 